BioPharmSignal logoBioPharmSignal

Biotech News

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Progyny (PGNY)ProgynyCompany update

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes from its Menopause and Midlife program and exhibit at The Menopause Society

Related news

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-09-03 15:17 EST

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

DAREDare Bioscience, Inc.2020-02-05 13:00 EST

Daré Bioscience to Present at the 2020 BIO CEO & Investor Conference

DAREDare Bioscience, Inc.2019-10-07 12:00 EST

Daré Bioscience to Present an Overview on its Intravaginal Ring (IVR) Technology in Development for Sustained-Release Hormone Therapy and Pregnancy Maintenance at the 9th Annual Partnership Opportunities in Drug Delivery Conference

HSTMHealthStream2026-09-14 13:25 EST

HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)

MGRXMANGOCEUTICALS2025-02-12 13:00 EST

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

COOThe Cooper Companies2025-12-29 21:15 EST

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

COOThe Cooper Companies2025-12-04 21:20 EST

CooperCompanies Announces New Chair of the Board and Strategic Review

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-11-04 21:01 EST

Progyny, Inc. Announces Third Quarter 2026 Results

PGNYProgyny2026-10-28 13:52 EST

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-10-15 13:35 EST

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Stock data

Close
34.37 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States